Post

Tatyana Golikova: More than 2,800 palliative care units and specialized institutions have been established in Russia.

Tatyana Golikova: More than 2,800 palliative care units and specialized institutions have been established in Russia.

Published on: 2026-09-29

Source: Government of the Russian Federation –

An important disclaimer is at the bottom of this article.

Tatiana Golikova took part in the All-Russian scientific-practical conference “Improving the accessibility and quality of medical care using narcotic and psychotropic drugs.”

Deputy Prime Minister Tatyana Golikova took part in the all-Russian scientific and practical conference “Improving the availability and quality of medical care using narcotic and psychotropic drugs.” The conference discussed the availability of effective pain relief, the development of domestic drug production, and improving the quality of medical care.

As Tatiana Golikova noted, in 2019 a meeting of the Council under the Government on Social Care Issues was held at the Moscow Endocrine Plant, following which key decisions were made regarding changes in legislation to eliminate legal gaps in the provision of palliative medical care, simplify the prescription of pain-relieving drugs, change the validity periods of prescriptions for them, increase the number of palliative beds in the regions, develop mobile home care services, support the creation of hospices, and other measures.

In the same year, amendments were made to the federal law “On the Fundamentals of Citizens’ Health” that specified the foundations for providing palliative medical care as a distinct type of medical care.

In 2016, at the initiative of council members, the first “roadmap” was adopted. Subsequently, in 2020, the Council under the Government on Social Care Issues approved the second, more extensive and comprehensive “roadmap” to improve the quality and accessibility of palliative medical care.

“As a result of the implementation of these two documents, the necessary infrastructure has been created, including more than 2,800 units of palliative care, home visit nursing care, nursing care departments and homes, as well as specialized institutions. The main activities to improve the availability and quality of palliative medical care are carried out within the framework of the state program ‘Healthcare Development.’ Approximately 3 billion rubles are allocated annually from the federal budget for these purposes, and almost 1 billion rubles more are directed by the regions,” said Tatyana Golikova.

Palliative care is provided under the State Guarantees Program for free medical care to citizens. In total, regions allocate about 50 billion rubles annually for these purposes.

“Special attention is paid to the availability of palliative care at home and the provision of medical devices. Only last year, 66.5 thousand patients received it – 13 thousand more than in 2024. For regional medical organizations providing palliative care, more than 5.8 million units of medical devices for home use were purchased in 2025,” noted Tatyana Golikova.

A significant component of palliative care is the relief of pain syndrome. Therefore, ensuring patients have access to pain relief medications is one of the priorities of the work. Over 10 years, the volume and range of produced narcotic and psychotropic medicinal products have expanded from 16 to 29, with production growth of 55%. The number of produced forms and dosages has tripled. The number of citizens provided with a two-month course of opioid analgesic pain relief has increased more than tenfold.

To prevent disruptions in the supply of such medications to patients, the Government conducts continuous monitoring, which allows for prompt response to any possible risks.

“Thanks to the decisions made by the head of state, it has been possible to ensure the production of pain relief medications using domestic raw materials, and by 2030 we plan to launch a plant for the production of the necessary substances. All this creates a foundation for localizing the full cycle production of domestic pain relief drugs, which means it guarantees import independence and drug security in the corresponding segment in our country. These strategic issues, as well as the improvement of regulatory legal framework, expansion of the range of drugs and points of sale network, and staffing issues received their confirmation and development in the already third “roadmap,” which was adopted by the Government in June of this year,” Tatiana Golikova emphasized.

In conclusion, the Deputy Prime Minister thanked the director of the Moscow Endocrine Plant, Mikhail Fonaryov, and the team for organizing the event.

Please note; This information is raw content obtained directly from the information source. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.